Pathstone Family Office’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $604K | Buy |
|
|||||
|
2023
Q2 | $578K | Buy |
|
|||||
|
2023
Q1 | $385K | Sell |
|
|||||
|
2022
Q4 | $891K | Buy |
|
|||||
|
2022
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $236K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $0 | Hold |
|
|||||
|
2020
Q3 | $0 | Sell |
|
|||||
|
2020
Q2 | $0 | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Buy |
|